Research Article
Effect of Moxibustion on HIF-1α and VEGF Levels in Patients with Rheumatoid Arthritis
Table 2
Clinical Symptoms and RA-associated serum markers.
| Outcome measure | Treatment group (n = 20) | Control group (n = 17) | value |
| Clinical symptoms | | | | VAS score, mean (SD) | 3.10 (1.52) | 5.88 (1.69) | <0.001† | Morning stiffness score, mean (SD) | 2.00 (1.30) | 3.41 (1.37) | 0.003† | Tenderness index, mean (SD) | 1.56 (0.30) | 2.62 (0.26) | <0.001† | Swelling index, mean (SD) | 1.40 (0.38) | 2.44 (0.38) | <0.001† | DAS28 score, mean (SD) | 4.92 (1.18) | 6.32 (1.02) | 0.001† | RA-associated serum markers | | | | ESR (mm/60 min), mean (SD) | 37.20 (28.20) | 38.53 (23.17) | 0.831△ | CRP (mg/L), mean (SD) | 5.61 (6.90) | 6.83 (4.95) | 0.070△ | RF (IU/ml), mean (SD) | 120.15 (154.60) | 158.38 (189.37) | 0.392△ |
|
|
† value by independent samples t-test. △ value by Mann–Whitney U test. |